ChengDu ShengNuo BiotecLtd Balance Sheet Health
Financial Health criteria checks 5/6
ChengDu ShengNuo BiotecLtd has a total shareholder equity of CN¥896.6M and total debt of CN¥287.0M, which brings its debt-to-equity ratio to 32%. Its total assets and total liabilities are CN¥1.4B and CN¥458.2M respectively. ChengDu ShengNuo BiotecLtd's EBIT is CN¥83.0M making its interest coverage ratio 14.6. It has cash and short-term investments of CN¥260.2M.
Key information
32.0%
Debt to equity ratio
CN¥287.04m
Debt
Interest coverage ratio | 14.6x |
Cash | CN¥260.24m |
Equity | CN¥896.57m |
Total liabilities | CN¥458.21m |
Total assets | CN¥1.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688117's short term assets (CN¥588.9M) exceed its short term liabilities (CN¥302.4M).
Long Term Liabilities: 688117's short term assets (CN¥588.9M) exceed its long term liabilities (CN¥155.8M).
Debt to Equity History and Analysis
Debt Level: 688117's net debt to equity ratio (3%) is considered satisfactory.
Reducing Debt: 688117's debt to equity ratio has increased from 2.1% to 32% over the past 5 years.
Debt Coverage: 688117's debt is well covered by operating cash flow (27.7%).
Interest Coverage: 688117's interest payments on its debt are well covered by EBIT (14.6x coverage).